AI assistant
Sending…
ABVC BIOPHARMA, INC. — Director's Dealing 2021
Dec 10, 2021
34380_dirs_2021-12-10_935829cd-6880-48b1-a30d-e3881e208217.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ABVC BIOPHARMA, INC. (ABVC)
CIK: 0001173313
Period of Report: 2021-08-02
Reporting Person: Sakamoto Norimi (Director)
More from ABVC BIOPHARMA, INC.
Interim / Quarterly Report
2026
May 18
Regulatory Filings
2026
Mar 27
Report Publication Announcement
2026
Mar 3
Annual Report
2026
Mar 3
Interim / Quarterly Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Jan 16
Regulatory Filings
2025
Dec 2
Regulatory Filings
2025
Nov 26